None listed
Conditions
Interventions
None listed
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with a diagnosis of HF and prescribed with sacubitril/valsartan, and with following conditions: (1) left ventricular ejection fraction (LVEF) =40% (2) on an ACEI or an ARB at a stable dose, with standard medical therapy (beta blockers and mineralocorticoid antagonists), for at least 4 weeks (3) hospitalized for acutely decompensated heart failure with reduced ejection fraction, and hemodynamically stabilized, regardless of the preceding use of ACEI or ARB
Exclusion criteria
Exclusion criteria: (1) Patients <19 years of age (2) Patients with active malignancy or those who underwent surgery for malignancy within 5 years of enrollment (3) Paitents whose medical records cannot confirm the occurrence of cardiovascular events or death
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular death or hospitalization for heart failure | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular death;Hospitalization for heart failure;All-cause death | — |
Countries
Korea, Republic of
Contacts
Public ContactIn-Chang Hwang
Seoul National University Bundang Hospital
Outcome results
None listed